<DOC>
	<DOCNO>NCT02234479</DOCNO>
	<brief_summary>The aim study compare effect Medihoney Hydrophor radiation dermatitis reaction group woman undergo radiation therapy breast cancer . It hop outcome pilot study provide evidence support use Medihoney prevent treat radiation dermatitis well sufficient preliminary data expand study large , federally fund research ( R01 ) look beneficial aspect Medihoney across spectrum radiation dermatitis mucositis several disease setting .</brief_summary>
	<brief_title>MediHoney Radiation Dermatitis</brief_title>
	<detailed_description>Background : Radiation dermatitis , also know radiodermatitis radiation skin reaction , widely report side effect radiation therapy cancer . The common radiation therapy-induced side effect acute skin reaction , range mild erythema confluent moist desquamation . Almost patient receive radiation therapy risk develop radiation dermatitis ( Trueman , 2012 ) . When manage appropriately , radiation dermatitis affect patient ' physical functioning quality life . It also cause pain discomfort may result infection and/or interruption treatment ( Feight et al. , 2011 ) . An important role oncology nurse educate , assess , monitor patient radiation dermatitis . Many nursing intervention use , include base tradition , physician preference , publish report . In routine practice , intervention radiation dermatitis institution-specific reliably evidence base . At investigator institution , Hydrophor ( Aquaphor ) , ointment contain petrolatum , mineral oil , ceresin , lanolin alcohol current standard care prevent treat radiation dermatitis . Some woman treatment breast cancer report dislike smell and/or texture Hydrophor . Rarely report side effect include allergic reaction , burning , sting , and/or redness . Honey ancient remedy recently show promising result treat burn , oral infection , promote surgical wound heal palliation . The topical application honey report advantageous radiation mucositis ( Biswal et al. , 2003 ) . In continue effort identify treatment option make investigator patient comfortable reduce complication radiation dermatitis , investigator interest conduct small pilot study compare effectiveness honey-based treatment ( Medihoney ) investigator current standard care ( Hydrophor ) .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Radiodermatitis</mesh_term>
	<criteria>Breast cancer treat either lumpectomy mastectomy ( without reconstruction ) . The patient must female . Radiation therapy plan whole breast/chestwall area ( include lymph node radiation ; conventional 3D radiation , IMRT/IGRT , hypofractionation allow ) . Age â‰¥ 18 year old . Previous radiation therapy chest area would result overlap radiation field . Wound care issue . Patients undergoing concurrent cytotoxic chemotherapy radiation therapy ( concurrent Herceptin and/or tamoxifen/aromatase inhibitor RT allow ) . Patients receive HDR ( savi mammosite ) brachytherapy treatment . Patients allergy and/or sensitivity Hydrophor , honey , and/or Medihoney . Immunocompromised status . Age &lt; 18 year old .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Radiation Dermatitis</keyword>
</DOC>